S'abonner

The prevalence of nonalcoholic fatty liver disease in Chinese adults screened by vibration controlled transient elastography and its diagnostic discrepancy compared with ultrasound - 01/10/22

Doi : 10.1016/j.clinre.2022.101951 
Yuqing Ding a, b, 1, Longfeng Jiang c, 1, Quanrongzi Wang d, 1, Wei Zhao a, b, Xiaohua Zhou a, b, Jing Lu a, b, e, Ting Tian a, b, Chengxiao Yu a, b, Xin Xu a, b, Wen Guo e, Qun Zhang e, , Ci Song a, b,
a Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, China 
b Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Medicine, Nanjing Medical University, Nanjing 211166, China 
c Department of Infectious Disease, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, 300 Guangzhou Road, Nanjing 210003, China 
d Department of Radiology, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, 300 Guangzhou Road, Nanjing 210003, China 
e Health Promotion Center, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, 300 Guangzhou Road, Nanjing 210003, China 

Corresponding authors at: Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, China; Health Promotion Center, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, 300 Guangzhou Road, Nanjing 210003, ChinaDepartment of EpidemiologyCenter for Global HealthSchool of Public HealthNanjing Medical University101 Longmian Avenue, NanjingNanjing211166China

Highlights

What is already known on this subject? Ultrasound and vibration controlled transient elastography (VCTE) are more commonly used for non-alcoholic fatty liver disease (NAFLD) screening.
What are the new findings? VCTE can identify participants who were older, fatter, had a worse metabolic and biochemical profile when compared with ultrasound.
How might it impact on clinical practice in the foreseeable future? VCTE is suggested as a more practical non-invasive tool for the screening and follow-up of NAFLD in China.

Le texte complet de cet article est disponible en PDF.

Abstract

Background

The prevalence of non-alcoholic fatty liver disease (NAFLD) in China as assessed using vibration-controlled transient elastography (VCTE) and its consistency with ultrasound is still unknown. We aimed to conduct a head-to-head comparison of consecutive measurements of NAFLD with ultrasound or VCTE to evaluate the discrepancy in the prevalence and distribution of NAFLD screened by two non-invasive techniques.

Methods

We collected VCTE and ultrasound examination data from 4,388 participants who underwent health check-ups at the Health Promotion Center of Jiangsu Province Hospital between January 2017 and December 2019. The major outcome was the presence of hepatic steatosis, which was defined as a median controlled attenuation parameter (CAP) ≥ 248 dB/m by VCTE or the definition of steatosis by ultrasound.

Results

Among the 4,388 participants, 2,214 were diagnosed with NAFLD by VCTE (CAP ≥ 248 dB/m, 50.46%). Participants with severe steatosis (CAP ≥ 280 dB/m) were commonly male (77.94% vs. 50.38%, P < 0.001), were obese (45.09% vs. 1.79%, P < 0.001), had a worse metabolic profile, had elevated liver enzyme levels, and had advanced fibrosis. The prevalence of ultrasound-diagnosed NAFLD was 56.42%. After consistency analysis, VCTE and ultrasound showed moderate agreement regarding the diagnosis of NAFLD (κ = 0.475). We then compared the characteristics and clinical features of the four groups classified by the diagnosis results of the two techniques. NAFLD participants diagnosed by VCTE only were older, more obese, and had worse metabolic and biochemical profiles than NAFLD participants diagnosed by ultrasound only; in particular, the former had a higher proportion of abnormal alanine aminotransferase and aspartate aminotransferase levels and a higher proportion of advanced fibrosis than the latter.

Conclusions

More than half of Chinese adults were affected by NAFLD according to VCTE. Screening based on VCTE is more likely to identify NAFLD patients with severe clinical features than ultrasound. Therefore, VCTE is a more practical non-invasive tool for the screening and follow-up of NAFLD in China.

Le texte complet de cet article est disponible en PDF.

Keywords : NAFLD, Prevalence, VCTE, Ultrasound

Abbreviations : NAFLD, VCTE, CAP, LSM, BMI, HbA1c, ALT, AST, GGT, FIB-4, APRI, LDL, HDL, ALP, AFP, IQR, SD


Plan


© 2022  Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 46 - N° 8

Article 101951- octobre 2022 Retour au numéro
Article précédent Article précédent
  • Covid19 vaccination-associated portal vein thrombosis—An interdisciplinary clinical challenge
  • Niklas Bogovic, Axel Doenecke, Christina Hart, Lukas Lürken, Susanne Heimerl, Christoph Eissnert, Hans J. Schlitt, Florian Bitterer
| Article suivant Article suivant
  • Thromboembolism and bleeding in patients with atrial fibrillation and liver disease – A nationwide register-based cohort study : Thromboembolism and bleeding in liver disease
  • Kamilla Steensig, Manan Pareek, Anne Lund Krarup, Peter Sogaard, Michael Maeng, Bhupendar Tayal, Christina Ji-Young Lee, Christian Torp-Pedersen, Gregory YH Lip, Peter Holland-Fischer, Kristian Hay Kragholm

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.